Latest News and Press Releases

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology EMR Software Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Ophthalmology EMR Software...

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...

ALISO VIEJO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational...

BVI appoints Jim Hollingshead as President & CEO, succeeding Shervin Korangy, to lead the company’s next phase of global growth and innovation.

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Uveitis - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2...

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Achromatopsia Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Achromatopsia Market is experiencing...

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Artificial Iris Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artificial Iris Market has shown...

MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...

Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in Stargardt disease patients MALVERN, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) --...